乳児臨床栄養の世界市場分析

世界の乳児臨床栄養の市場規模は、2021年に448億米ドルとなりました。

同市場は、2021年～2026年の予測期間中に6.5％のCAGRで拡大し、2026年には615億米ドルに達すると予測されています。

当レポートでは、世界の乳児臨床栄養市場について調査し、市場の概要とともに、栄養タイプ別、形態別、地域別動向、COVID-19の影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 まとめとハイライト

第3章 市場力学

• 概要
• 市場力学
• 市場の促進要因
• 市場の抑制要因
• 市場の機会

第4章 市場概要

第5章 COVID-19の市場への影響

• 概要
• COVID-19の危機
• 乳児臨床栄養市場に対するCOVID-19の影響
• COVID-19がサプライチェーンに与える影響
• COVID-19の対策
• 現在の見通し

第6章 バリューチェーンとサプライチェーンの分析

第7章 乳児用調製粉乳市場の内訳

第8章 市場の内訳、栄養タイプ別

• 経腸栄養
• 経口栄養補助食品
• 経管栄養
• 経腸投与
• 経腸栄養ポンプ
• 非経口栄養
• 総経口栄養成分

第9章 市場の内訳、形態別

• 粉ミルク
• そのまま使える液体ミルク
• 濃縮液体ミルク

第10章 市場の内訳、地域別

• 概要
• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 市場機会の分析

• ポーターの分析
• PEST分析

第12章 競合情勢

第13章 企業プロファイル

• 主要企業
• ABBOTT
• BAXTER INTERNATIONAL INC.
• DANA DAIRY GROUP LTD
• DANONE S.A.
• FRESENIUS SE & CO. KGAA
• GLANBIA PLC
• NESTLE
• PERRIGO CO. PLC
• PROLACTA BIOSCIENCES INC.
• RECKITT BENCKISER GROUP PLC
• 新興企業
• AUSNUTRIA DAIRY CO. LTD.
• BABYLICIOUS LTD.
• BABYNAT ORGANIC
• DUTCH LADY MILK INDUSTRIES BERHAD
• ELLA'S KITCHEN
• FASSKA S.A.
• GOLDENCROPS CORP.
• GUANGDONG YASHILI GROUP CO. LTD.
• HERO GROUP
• HIPP ORGANIC BABY FOOD
• HOLLE BABY FOOD GMBH
• JIANGXI MEILU DAIRY CO. LTD.
• LO BELLO FOSFOVIT SRL
• MORINAGA MILK INDUSTRY CO. LTD.
• PBM PRODUCTS LLC
• SHANDONG YINGERLE HWA TAI FOOD INDUSTRY CO. LTD
• UNITED DAIRY LTD.
• YUBAO GOAT DAIRY CO. LTD.

第14章 付録：頭字語

List of Tables

• Summary Table A : Global Market for Clinical Infant Nutrition, by Type of Formula, Through 2026
• Summary Table B : Global Market for Clinical Infant Nutrition, by Region, Through 2026
• Table 1 : Evolution of Regulations
• Table 2 : Chinese Supervision System
• Table 3 : Food for Special Medical Purposes for People Over 1 Years Old
• Table 4 : Existing Foods for Special Medical Purposes for Infants Ages 0 Months to 12 months
• Table 5 : Planned Foods for Special Medical Purposes for Infants Ages 0 Months to 12 Months
• Table 6 : Exempt Infant Formulas Marketed in the U.S., by Manufacturer and Category
• Table 7 : Patents on Clinical Infant Nutrition Products, January 2010-June 2021
• Table 8 : Participants in Infant Nutrition Distribution Network
• Table 9 : Global Market for Clinical Infant Nutrition, by Type of Infant Formula, Through 2026
• Table 10 : Global Market for Specialized Clinical Infant Formula, by Region, Through 2026
• Table 11 : Global Market for Standard Clinical Infant Formula, by Region, Through 2026
• Table 12 : Global Market for Clinical Infant Nutrition, by Formula Type, Through 2026
• Table 13 : Enteral Feeding Devices
• Table 14 : Enteral Feeding Administration Methods
• Table 15 : Enteral Clinical Nutrition for Children, by Type
• Table 16 : Global Market for Enteral Nutrition, by Region, Through 2026
• Table 17 : Total Parental Nutrition Constituents for Children
• Table 18 : Global Market for Parental Nutrition, by Region, Through 2026
• Table 19 : Global Market for Clinical Infant Nutrition, by Type of Infant Formula, Through 2026
• Table 20 : Global Market for Powdered Formula, by Region, Through 2026
• Table 21 : Global Market for Ready-to-Feed Formulas, by Region, Through 2026
• Table 22 : Global Market for Concentrated Liquid Formulas, by Region, Through 2026
• Table 23 : Global Market for Clinical Infant Nutrition, by Region, Through 2026
• Table 24 : North American Market for Clinical Infant Nutrition, by Country, Through 2026
• Table 25 : European Market for Clinical Infant Nutrition, by Country, Through 2026
• Table 26 : Rest of the European Countries Mortality Rates in Children Less Than Age Five Years Old
• Table 27 : Asia-Pacific Market for Clinical Infant Nutrition, by Country, Through 2026
• Table 28 : Rest of the World Market for Clinical Infant Nutrition, by Country, Through 2026
• Table 29 : Rest of the World Countries Mortality Rate of Children Under the Age of Five Years Old
• Table 30 : Porter's Five Forces Analysis
• Table 31 : Abbott: Nutritional Product and Research and Development Investment, 2018-2020
• Table 32 : Abbott Nutrition: Clinical Infant Nutrition Products
• Table 33 : Abbott: Business Highlights, 2020
• Table 34 : Baxter International Inc.: Clinical Infant Nutrition Products
• Table 35 : Baxter International Inc.: Key Developments
• Table 36 : Dana Dairy: Clinical Infant Nutrition Products
• Table 37 : Danone: Clinical Infant Nutrition Products
• Table 38 : Danone: Key Developments, 2020
• Table 39 : Fresenius Kabi: Clinical Infant Nutrition Products
• Table 40 : Glanbia plc: Clinical Infant Nutrition Products
• Table 41 : Nestle: Clinical Infant Nutrition Products
• Table 42 : Nestle: Key Developments, 2017
• Table 43 : Perrigo Co. plc: Clinical Infant Nutrition Products
• Table 44 : Perrigo Co. plc: Key Developments, 2020
• Table 45 : Prolacta Bioscience Inc.: Clinical Infant Nutrition Products
• Table 46 : Mead Johnson: Clinical Infant Nutrition Products
• Table 47 : Acronyms Used in This Report

List of Figures

• Summary Figure A : Global Market Shares of Clinical Infant Nutrition, by Type of Formula, 2020
• Summary Figure B : Global Market for Clinical Infant Nutrition, by Region, 2018-2026
• Figure 1 : U.S. Market Shares of Exempt Infant Formulas, by Company, 2020
• Figure 2 : Infant Nutrition Value Chain: Overview
• Figure 3 : Global Market for Specialized Clinical Infant Formula, 2020-2026
• Figure 4 : Global Market for Standard Clinical Infant Formula, 2020-2026
• Figure 5 : Global Market for Enteral Nutrition, 2020-2026
• Figure 6 : Global Market for Parental Nutrition, 2020-2026
• Figure 7 : Global Market for Powdered Formula, 2020-2026
• Figure 8 : Global Market for Ready-to-Feed Formulas, 2020-2026
• Figure 9 : Global Market for Concentrated Liquid Formulas, 2020-2026
• Figure 10 : Global Market Shares of Clinical Infant Nutrition, by Region, 2020
• Figure 11 : North American Market for Clinical Infant Nutrition, 2020-2026
• Figure 12 : North American Market for Clinical Infant Nutrition, by Country, 2020-2026
• Figure 13 : North American Market Shares of Clinical Infant Nutrition, by Country, 2020
• Figure 14 : European Market for Clinical Infant Nutrition, 2020-2026
• Figure 15 : European Market for Clinical Infant Nutrition, by Country, 2020-2026
• Figure 16 : European Market Shares of Clinical Infant Nutrition, by Country, 2020
• Figure 17 : Undernourishment in Asia-Pacific, 2005-2016
• Figure 18 : Asia-Pacific Market for Clinical Infant Nutrition, 2020-2026
• Figure 19 : Asia-Pacific Market for Clinical Infant Nutrition, by Country, 2020-2026
• Figure 20 : Asia-Pacific Market Shares of Clinical Infant Nutrition, by Country, 2020
• Figure 21 : Rest of the World Market for Clinical Infant Nutrition, 2020-2026
• Figure 22 : Rest of the World Market for Clinical Infant Nutrition, by Country, 2020-2026
• Figure 23 : Rest of the World Market Shares of Clinical Infant Nutrition, by Country, 2020
• Figure 24 : Global Market Shares of Clinical Infant Nutrition, by Key Player, 2020
• Figure 25 : Abbott: Annual Revenue, 2018-2021
• Figure 26 : Abbott: Revenue Share, by Segment, 2021
• Figure 27 : Abbott Nutrition: Revenue Share, by Segment, 2021
• Figure 28 : Baxter International Inc.: Annual Revenue, 2018-2021
• Figure 29 : Baxter International Inc.: Revenue Share, by Segment, 2021
• Figure 30 : Baxter International Inc.: Revenue Share, by Clinical Nutrition, 2018-2021
• Figure 31 : Danone: Annual Revenue, 2018-2021
• Figure 32 : Danone: Revenue Share, by Segment, 2021
• Figure 33 : Fresenius SE & Co. KGaA: Annual Revenue, 2018-2021
• Figure 34 : Fresenius SE & Co. KGaA: Revenue Share, by Segment, 2021
• Figure 35 : Fresenius SE & Co. KGaA: Clinical Nutrition Revenue, 2018-2021
• Figure 36 : Glanbia plc: Annual Revenue, 2018-2021
• Figure 37 : Glanbia plc: Revenue Share, by Segment, 2021
• Figure 38 : Nestle: Annual Revenue, 2018-2021
• Figure 39 : Nestle: Revenue Share, by Segment, 2021
• Figure 40 : Perrigo Co. plc: Annual Revenue, 2018-2021
• Figure 41 : Perrigo Co. plc: Revenue Share, by Segment, 2021
• Figure 42 : Reckitt: Annual Revenue, 2018-2021

Highlights:

The global clinical infant nutrition market reached $44.8 billion in 2021 and should reach more than $61.5 billion by 2026, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2021-2026.

North American clinical infant nutrition market reached $16.8 billion in 2021 and should reach more than $23.2 billion by 2026, with a CAGR of 6.7% during the forecast period of 2021-2026.

Asia-Pacific clinical infant nutrition market reached $10.4 billion in 2021 and should reach more than $15 billion by 2026, with a CAGR of 7.5% during the forecast period of 2021-2026.

Report Scope:

The current report will provide detailed information regarding the infant nutrition market. It analyzes the market trends of infant nutrition with data from 2020, estimates from 2021, projections of compound annual growth rates (CAGR) through 2026 (i.e., forecast period 2021 through 2026) and regional markets of infant nutrition devices. This report will highlight the current and future market potential for infant nutrition, as well as a detailed analysis of the competitive environment. It report will cover regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2026 and the market shares for key market players.

Based on infant formulas, the market is segmented into specialized infant formulas and standard infant formulas. Based on nutrition type, the market is segmented into enteral and parenteral nutrition. The market is also segmented by powdered formula, concentrated liquid formula and ready-to-use formula.

The market has been segmented into various major geographic regions, including North America, Europe, Asia-Pacific and the Rest of the World. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Japan, China, India) will be covered within the regional segment. For market estimates, data are provided using 2020 as the base year, with estimates for 2021 and forecast value for 2026.

A holistic study of the market has been carried out, incorporating various factors, including country-specific demographic conditions and business cycles, and market-specific microeconomic influences needed to analyze future market trends. Key vendor analysis, new products, developments and financials are also provided to enable easy decision making.

Report Includes:

• 17 data tables and 32 additional tables
• An up-to-date overview and analysis of the global market for clinical infant nutrition
• Analyses of the global market trends, with historical sales data for 2018-2021, and projections of compound annual growth rates (CAGRs) through 2026
• Highlights of the current and future market potential for clinical infant nutrition, and areas of focus to forecast this market into various segments and sub-segments
• Evaluation and forecast the clinical infant nutrition market size, projected growth trends, and corresponding market share analysis segmented by nutrition type, formulation technique, product form, and geographic region
• Assessment of major driving factors, trends, opportunities and challenges in this innovation driven market, along with technology advances and regulatory implications within the marketplace
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
• Company profiles of major market players, including Abbott Laboratories, Baxter International Inc., Danone, Fresenius, Nestle, and Reckitt Benckiser Group Plc

Table of Contents

Chapter 1 Introduction

• Introduction
• Definition of Infant Formula
• Introduction to Breastfeeding
• Importance of Breast Milk
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of the Report
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Dynamics

• Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities

Chapter 4 Market Overview

• History of the Development of Infant Formula
• Regulatory Landscape
• North America
• Canada
• Europe
• Asia-Pacific
• Exempt Infant Formulas
• Future Perspective
• New Entrants and Their Product Pipelines
• Trends in Innovation
• Product Pricing Affecting Market Revenue
• Patent Review

Chapter 5 Impact of COVID-19 on the Market

• Overview
• COVID-19 Crisis
• Impact of COVID-19 on the Market for Clinical Infant Nutrition
• Impact of COVID-19 on the Supply Chain
• COVID-19 Measures
• Current Outlook

Chapter 6 Value Chain and Supply Chain Analysis

• Infant Nutrition Value Chain
• Infant Nutrition and New Zealand
• China
• Infant Nutrition Sales Channels
• Identification of Value-Added Services
• Infant Nutrition Supply Chain
• Recent Issues in the Supply Chain
• Shortage of Infant Formulas
• Infant Nutrition Industry: Supply Chain Strategy
• Distribution of Infant Nutrition

Chapter 7 Infant Formula Market Breakdown

• Specialized Infant Formulas
• Organic Formula
• Probiotics
• Prebiotics
• Preterm Formula
• Milk Formulas for Individuals with Inborn Errors of Metabolism
• Standard Infant Formula
• Milk-Based Formula
• Hydrolyzed and Soy-Based Formula

Chapter 8 Market Breakdown by Nutrition Type

• Enteral Nutrition
• Oral Nutritional Supplements
• Tube Feeding
• Enteral Feed Administration
• Enteral Feeding Pump
• Parenteral Nutrition
• Total Parental Nutrition Constituents

Chapter 9 Market Breakdown by Form

• Powdered Formula
• Ready-to-Feed Formulas
• Concentrated Liquid Formulas

Chapter 10 Market Breakdown by Region

• Overview
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Australia and New Zealand
• Rest of Asia-Pacific
• Rest of World

Chapter 11 Analysis of Market Opportunities

• Porter's Analysis
• Threat of New Entrants
• Threat of Substitutes
• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Competitive Rivalry and Degree of Competition
• PEST Analysis
• Political
• Economical
• Social
• Technology

Chapter 12 Competitive Landscape

• Major Players
• Major Share Analysis

Chapter 13 Company Profiles

• Major Companies
• ABBOTT
• BAXTER INTERNATIONAL INC.
• DANA DAIRY GROUP LTD
• DANONE S.A.
• FRESENIUS SE & CO. KGAA
• GLANBIA PLC
• NESTLE
• PERRIGO CO. PLC
• PROLACTA BIOSCIENCES INC.
• RECKITT BENCKISER GROUP PLC (MEAD JOHNSON & CO. LLC)
• Emerging Companies
• AUSNUTRIA DAIRY CO. LTD.
• BABYLICIOUS LTD.
• BABYNAT ORGANIC
• DUTCH LADY MILK INDUSTRIES BERHAD
• ELLA'S KITCHEN
• FASSKA S.A.
• GOLDENCROPS CORP.
• GUANGDONG YASHILI GROUP CO. LTD.
• HERO GROUP
• HIPP ORGANIC BABY FOOD
• HOLLE BABY FOOD GMBH
• JIANGXI MEILU DAIRY CO. LTD.
• LO BELLO FOSFOVIT SRL
• MORINAGA MILK INDUSTRY CO. LTD.
• PBM PRODUCTS LLC
• SHANDONG YINGERLE HWA TAI FOOD INDUSTRY CO. LTD
• UNITED DAIRY LTD.
• YUBAO GOAT DAIRY CO. LTD.

Chapter 14 Appendix: Acronyms